DK2326648T3 - Fremgangsmåde til fremstillingen af carbapenemforbindelser - Google Patents

Fremgangsmåde til fremstillingen af carbapenemforbindelser

Info

Publication number
DK2326648T3
DK2326648T3 DK09786765.9T DK09786765T DK2326648T3 DK 2326648 T3 DK2326648 T3 DK 2326648T3 DK 09786765 T DK09786765 T DK 09786765T DK 2326648 T3 DK2326648 T3 DK 2326648T3
Authority
DK
Denmark
Prior art keywords
preparation
carbapenem compounds
carbapenem
compounds
Prior art date
Application number
DK09786765.9T
Other languages
English (en)
Inventor
Neera Tewari
Shailendra K Singh
Brij Kishore Mishra
Saraswati Rani
Original Assignee
Ranbaxy Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Lab Ltd filed Critical Ranbaxy Lab Ltd
Application granted granted Critical
Publication of DK2326648T3 publication Critical patent/DK2326648T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D477/00Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D477/00Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/02Preparation
    • C07D477/04Preparation by forming the ring or condensed ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK09786765.9T 2008-07-30 2009-07-30 Fremgangsmåde til fremstillingen af carbapenemforbindelser DK2326648T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1808DE2008 2008-07-30
PCT/IB2009/053332 WO2010013223A1 (en) 2008-07-30 2009-07-30 Process for the preparation of carbapenem compounds

Publications (1)

Publication Number Publication Date
DK2326648T3 true DK2326648T3 (da) 2012-10-15

Family

ID=41066372

Family Applications (1)

Application Number Title Priority Date Filing Date
DK09786765.9T DK2326648T3 (da) 2008-07-30 2009-07-30 Fremgangsmåde til fremstillingen af carbapenemforbindelser

Country Status (9)

Country Link
US (1) US8841444B2 (da)
EP (1) EP2326648B1 (da)
KR (1) KR20110049823A (da)
AU (1) AU2009277936B2 (da)
CA (1) CA2732619A1 (da)
DK (1) DK2326648T3 (da)
ES (1) ES2391713T3 (da)
PT (1) PT2326648E (da)
WO (1) WO2010013223A1 (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8293894B2 (en) * 2006-11-20 2012-10-23 Orchid Chemicals & Pharmaceuticals Limited Process for the preparation of carbapenem antibiotic
WO2011048583A1 (en) * 2009-10-23 2011-04-28 Ranbaxy Laboratories Limited Process for the preparation of carbapenem compounds
US8580985B2 (en) * 2011-12-19 2013-11-12 Biosynthetic Technologies, Llc Processes for preparing estolide base oils and oligomeric compounds that include cross metathesis

Family Cites Families (81)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4260543A (en) * 1978-07-03 1981-04-07 Merck & Co., Inc. Crystalline N-formimidoyl thienamycin
US4273709A (en) * 1979-07-23 1981-06-16 Merck & Co., Inc. Process for the preparation of thienamycin and intermediates
US4262010A (en) * 1979-12-03 1981-04-14 Merck & Co., Inc. 6-(1-Hydroxyethyl)-2-(2-aminoethylthio)-1,1-disubstituted-1-carbadethiapen-2-em-3-carboxylic acids
US4312871A (en) * 1979-12-03 1982-01-26 Merck & Co., Inc. 6-, 1- And 2-substituted-1-carbadethiapen-2-em-3-carboxylic acids
US4282148A (en) * 1980-01-14 1981-08-04 Merck & Co., Inc. Synthesis of thienamycin via esters of (3SR, 4RS)-3-[(SR)-1-hydroxyethyl]-β,2-dioxo-4-azetidinebutanoic acid
US4499278A (en) * 1980-01-14 1985-02-12 Merck & Co., Inc. Trans-3-carboxymethylene-4-carboxy-5-methyl-delta2-isoxazoline as intermediate
US4350631A (en) * 1980-12-18 1982-09-21 Merck & Co., Inc. 6- and 4-Substituted-1-azabicyclo[3.2.0]heptan-3,7-dione-2-carboxylates
US4360684A (en) * 1981-04-08 1982-11-23 Merck & Co., Inc. Process for the preparation of (2S)-tetrahydro-2α-methyl-6-oxo-4βα-carboxylic acid
US4552873A (en) 1981-08-19 1985-11-12 Sankyo Company Limited Carbapenem compounds, and compositions containing them
US4683296A (en) * 1983-03-07 1987-07-28 Bristol-Myers Company Carbapenem intermediates
CA1283906C (en) * 1983-05-09 1991-05-07 Makoto Sunagawa .beta.-LACTAM COMPOUNDS AND PRODUCTION THEREOF
US5310897A (en) * 1984-12-27 1994-05-10 Sumitomo Pharmaceuticals Co., Ltd. Beta-lactams and their production
US5104984A (en) * 1985-03-29 1992-04-14 Merck & Co., Inc. Enantioselective process for producing 1-beta-methyl carbapenem antibiotic intermediates
US4833167A (en) * 1985-06-10 1989-05-23 Merck & Co., Inc. 2-aza-substituted 1-carbadethiapen-2-em-3-carboxylic acids
EP0213610A1 (en) * 1985-08-31 1987-03-11 Lederle (Japan) Ltd. Azetidin-2-one derivatives and process for production thereof
JPS62169781A (ja) 1986-01-21 1987-07-25 Sankyo Co Ltd β−ラクタム化合物
US5231179A (en) * 1986-01-27 1993-07-27 Sumitomo Pharmaceuticals Company, Limited Heterocyclic compounds and their production
EP0243686B1 (en) * 1986-03-27 1992-07-15 Sumitomo Pharmaceuticals Company, Limited Beta-lactam compounds, and their production
GB8607921D0 (en) * 1986-04-01 1986-05-08 Fujisawa Pharmaceutical Co 3,4-disubstituted-2-azetidinone derivatives
IE60588B1 (en) * 1986-07-30 1994-07-27 Sumitomo Pharma Carbapenem compound in crystalline form, and its production and use
JPS63112558A (ja) 1986-10-30 1988-05-17 Fujisawa Pharmaceut Co Ltd 4−(1−置換アリル)−2−アゼチジノン化合物の製造方法
JP2510860B2 (ja) 1987-02-02 1996-06-26 住友製薬株式会社 新規なβ−ラクタム誘導体の製造方法
US4866171A (en) * 1987-04-11 1989-09-12 Lederle (Japan), Ltd. (1R,5S,6S)-2-[(6,7-dihydro-5H-pyrazolo[1,2-a][1,2,4]triazolium-6-yl)]thio-6-[R-1-hydroxyethyl]-1-methyl-carbapenum-3-carboxylate
JPS63284176A (ja) 1987-05-15 1988-11-21 Nippon Redarii Kk (1r,5r,6s)−6−〔(1r)−1−ヒドロキシエチル〕−1−メチルカルバペネム−3−カルボン酸誘導体の高立体選択的製造方法
EP0300657B1 (en) 1987-07-17 1993-03-31 Merck & Co. Inc. 4-substituted 3-oxobutanoate ester derivatives
DK168047B1 (da) * 1987-12-07 1994-01-24 Lederle Japan Ltd (1r,5s,6s)-2-substitueret thio-6-oe(r)-1-hydroxyethylaa-1-methyl-carbapenem-3-carboxylsyrederivater, fremgangsmaade til remstilling deraf, midler og praeparater indeholdende den krystallinske forbindelse samt dens anvendelse.
JP2592110B2 (ja) 1988-09-27 1997-03-19 日本レダリー株式会社 カルバペネム化合物の製造法
JPH02178262A (ja) 1988-12-28 1990-07-11 Sumitomo Pharmaceut Co Ltd 1―(2′―ハロプロピオニル)ピロリジン―2―オン誘導体
JPH0380417A (ja) 1989-08-23 1991-04-05 Tdk Corp 磁気記録媒体および磁気記録媒体の製造方法
JPH03219833A (ja) 1990-01-24 1991-09-27 Mitsubishi Electric Corp 冷凍えびおよびその製造方法
CA2036960A1 (en) 1990-02-26 1991-08-27 Thomas A. Rano Novel synthesis of carbapenem intermediates
JPH04117382A (ja) 1990-09-06 1992-04-17 Tanabe Seiyaku Co Ltd 1―メチルカルバペネム誘導体及びその製法
JP3080417B2 (ja) 1991-02-28 2000-08-28 日本ワイスレダリー株式会社 結晶形態の1−メチル−2−ジフエニルホスホリルオキシ−カルバペネム化合物
JP3219833B2 (ja) 1991-03-30 2001-10-15 日本ワイスレダリー株式会社 4−置換プロピルアゼチジン−2−オン誘導体の製造方法
JPH04368365A (ja) 1991-06-18 1992-12-21 Sankyo Co Ltd アゼチジノン誘導体の製法
JPH04368386A (ja) 1991-06-18 1992-12-21 Sankyo Co Ltd 1−メチルカルバペネム−3−カルボン酸の製造法
US5317016A (en) * 1991-08-20 1994-05-31 Shionogi Seiyaku Kabushiki Kaisha Pyrrolidylthiocarbapenem derivative
JP2902178B2 (ja) 1991-10-15 1999-06-07 鐘淵化学工業株式会社 4−(1,2−置換または非置換アリル)−2−アゼチジノン化合物からのカルバペネム合成中間体の製造法
DE69231883T2 (de) * 1991-12-09 2001-10-04 Takasago International Corp., Tokio/Tokyo 4-(1,1-Dialkoxycarbonyl-Alkyl)Azetidin-2-on-Derivate zur Herstellung von 4-(1-Carboxy-Alkyl)Azetidin-2-on-Derivaten
US5731431A (en) * 1991-12-26 1998-03-24 Nippon Soda Co., Ltd. Process for preparing 4-substituted azetidinone derivatives
GB9202298D0 (en) * 1992-02-04 1992-03-18 Ici Plc Antibiotic compounds
JP2569455B2 (ja) * 1992-03-06 1997-01-08 田辺製薬株式会社 β−ラクタム誘導体の製法
EP0567949B1 (en) * 1992-04-28 2001-02-21 Tanabe Seiyaku Co., Ltd. Method for removing silyl protecting groups for hydroxy group
US5587474A (en) * 1992-06-18 1996-12-24 Tanabe Seiyaku Co., Ltd. Method for removing the protecting group for carboxyl group
JP3479720B2 (ja) 1992-07-08 2003-12-15 武田薬品工業株式会社 カルバペネム類の製造法
JPH0665195A (ja) 1992-08-24 1994-03-08 Banyu Pharmaceut Co Ltd β−ラクタム誘導体の新規な製造法
US6011150A (en) * 1992-11-13 2000-01-04 Tanabe Seiyaku Co., Ltd. Azetidinone compound and process for preparation thereof
US5442055A (en) 1992-11-13 1995-08-15 Tanabe Seiyaku Co., Ltd. Azetidinone compound and process for preparation thereof
US5338875A (en) * 1992-11-19 1994-08-16 Merck & Co., Inc. Boron containing intermediates useful in the preparation of carbapenems
ATE200674T1 (de) * 1993-02-10 2001-05-15 Shionogi & Co Herstellung von beta-lactamverbindungen und zwischenprodukte
US6867297B1 (en) * 1993-02-12 2005-03-15 Daiichi Suntory Pharma Co., Ltd. Process for synthesizing 4-substituted azetidinone derivatives
JP3197116B2 (ja) 1993-06-14 2001-08-13 富士写真光機株式会社 フイルムキャリアの可変マスク装置
US5550229A (en) * 1993-06-23 1996-08-27 Tanabe Seiyaku Co., Ltd. Alkylation process for preparing azetidinone compound and starting compound therefor
JPH0713058A (ja) 1993-06-25 1995-01-17 Hitachi Electron Eng Co Ltd 対物レンズの光軸調整方法
DE69405922T2 (de) * 1993-06-30 1998-01-29 Nippon Soda Co Verfahren zur Herstellung von 4-substituierten Azetidinon-Derivaten
US5493018A (en) * 1994-01-25 1996-02-20 Merck & Co., Inc. Process for synthesizing carbapenem intermediates using a rhodium catalyst and lewis acid
US5578722A (en) * 1994-03-29 1996-11-26 Sumitomo Pharmaceuticals Co., Ltd. Process for preparing carbapenem compounds
JP3388874B2 (ja) 1994-04-06 2003-03-24 住友製薬株式会社 β−ラクタム化合物の製造方法
JP3787819B2 (ja) 1994-07-14 2006-06-21 日本曹達株式会社 アゼチジノン化合物及びその製造方法
JP3761096B2 (ja) 1994-12-20 2006-03-29 塩野義製薬株式会社 2−アルキル置換カルバペネム誘導体の製造方法
JP3834798B2 (ja) 1995-05-16 2006-10-18 日本曹達株式会社 アゼチジノン化合物の製造方法
JPH08325261A (ja) 1995-05-26 1996-12-10 Nippon Soda Co Ltd アゼチジノン化合物の製造方法
AR002507A1 (es) 1995-06-28 1998-03-25 Merck & Co Inc Proceso mejorado para sintetizar intermediarios de carbapenem
JPH0931054A (ja) 1995-07-17 1997-02-04 Nippon Soda Co Ltd アゼチジノン化合物及びその製造方法
JPH0931075A (ja) 1995-07-19 1997-02-04 Nippon Soda Co Ltd カルバペネム中間体の製造方法
JP3954670B2 (ja) 1996-05-28 2007-08-08 株式会社カネカ カルバペネム抗生物質中間体の製造法
JPH1077263A (ja) 1996-09-05 1998-03-24 Nippon Soda Co Ltd アゼチジノン誘導体の製造方法
JP4170405B2 (ja) 1996-09-06 2008-10-22 日本曹達株式会社 アゼチジノン誘導体の製造法
US5973142A (en) * 1997-01-21 1999-10-26 Yasuda; Nobuyoshi Process for synthesizing carbapenem intermediates
US6080854A (en) * 1997-08-25 2000-06-27 Merck & Co., Inc. Process for synthesizing carbapenem intermediates
US6162911A (en) * 1997-09-09 2000-12-19 Merck & Co., Inc. Crystalline imidazole complexes as carbapenem intermediates and synthesis
JP2000007676A (ja) 1998-06-23 2000-01-11 Nippon Soda Co Ltd カルバペネム化合物の製造方法
JP3450193B2 (ja) * 1998-07-24 2003-09-22 高砂香料工業株式会社 4−置換アゼチジノン誘導体の製造方法
JP4283913B2 (ja) 1998-07-30 2009-06-24 株式会社カネカ 4−置換アゼチジニルペンタン酸誘導体の製造法
JP4028098B2 (ja) 1998-07-30 2007-12-26 株式会社カネカ カルバペネム抗生物質中間体の製造方法
KR100377448B1 (ko) * 2000-08-10 2003-03-26 동화약품공업주식회사 카바페넴 항생물질의 중간체 및 그의 제조방법
US20020049315A1 (en) 2000-09-06 2002-04-25 Williams John M. Crystalline forms of carbapenem intermediates
JP4274739B2 (ja) 2001-05-10 2009-06-10 塩野義製薬株式会社 アセチルチオピロリジン誘導体の製法
JP2002338572A (ja) 2002-03-22 2002-11-27 Takeda Chem Ind Ltd カルバペネム類の製造法
JP2003277390A (ja) 2002-03-25 2003-10-02 Takasago Internatl Corp アゼチジノン化合物の製造方法
JP3467265B2 (ja) 2002-07-31 2003-11-17 日本ワイスレダリー株式会社 アゼチジノン化合物の結晶

Also Published As

Publication number Publication date
AU2009277936A1 (en) 2010-02-04
PT2326648E (pt) 2012-10-31
WO2010013223A1 (en) 2010-02-04
CA2732619A1 (en) 2010-02-04
EP2326648B1 (en) 2012-09-19
AU2009277936B2 (en) 2014-11-27
US20110224426A1 (en) 2011-09-15
KR20110049823A (ko) 2011-05-12
ES2391713T3 (es) 2012-11-29
US8841444B2 (en) 2014-09-23
EP2326648A1 (en) 2011-06-01

Similar Documents

Publication Publication Date Title
DK2046767T3 (da) Fremgangsmåde til fremstilling af diaminophenothiaziniumforbindelser
DK2114886T3 (da) Fremgangsmåde til fremstilling af visse substituerede sulfiliminer
DK2086944T3 (da) Fremgangsmåde til fremstilling af difluormethylpyrazolylcarboxylater
DK2346888T3 (da) Fremgangsmåde til fremstilling af som SGLT-inhibitorer anvendelige forbindelser
DK3289876T3 (da) Forbindelser til behandling af cancer
DK2285779T3 (da) Fremgangsmåde til fremstilling af arylcarboxamider
DK3301074T3 (da) Fremgangsmåde til fremstilling af aluminiumphosphat
DK2155838T3 (da) Fremgangsmåde til fremstilling af forgrenede carbonhydrider
DK2334639T3 (da) Fremgangsmåder til fremstilling af aminosulfonforbindelser
DK2220021T3 (da) Fremgangsmåde til fremstilling af terephtalsyre
BRPI0908353A2 (pt) Compostos
DK2382232T3 (da) Fremgangsmåde til fremstilling af bivalirudin
DK2209900T3 (da) Anvendelse af bakterier til fremstillingen af bioenergi
DK2311970T3 (da) Fremgangsmåde til fremstillingen af bioprodukter
DK2593449T3 (da) Fremgangsmåde til syntese af benzothiadiazolforbindelse
HUE052219T2 (hu) Eljárás kinolon vegyületek elõállítására
DK2358732T3 (da) Fremgangsmåde til syntetisering af makrolidforbindelser
DK2358661T3 (da) Fremgangsmåde til fremstilling af trans-4-amino-cyclohexyl-eddikesyreethylester-hcl
DK2213654T3 (da) Fremgangsmåde til fremstilling af 2-amino-5-brombenzamid derivater
DK2209784T3 (da) Forbindelser til behandling af hepatitis C
DK2160225T3 (da) Fremgangsmåde til fremstilling af krystaller
DK2307441T3 (da) Fremgangsmåde til fremstilling af insulinforbindelser
DK2317877T3 (da) Fremgangsmåde til filtrering af mælk
DK2516359T3 (da) Fremgangsmåde til fremstilling af ethylbenzen
DK2462108T3 (da) Fremgangsmåde til fremstilling af pyrazolcarboxylsyreamider